26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
An agreement to arbitrate sexual harassment claims is enforceable, according to a recent decision ha...
Read More >
A reminder to New Jersey employers that the new law prohibiting employers from screening job applica...
Read More >
As we’ve previously reported, paid family leave laws have been sweeping the country. While employe...
Read More >
On Friday afternoon, January 24, 2020, the U.S. Department of Health and Human Services (HHS), Offic...
Read More >
Seyfarth synopsis: The Supreme Court has just granted certiorari in a case regarding the question of...
Read More >
Beginning January 1, 2020, the American Arbitration Association (AAA) will: (i) reduce filing fees c...
Read More >